Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00469521
First received: May 2, 2007
Last updated: September 5, 2007
Last verified: September 2007
  Purpose

To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.


Condition Intervention Phase
Tear Film Thickness
Drug: Refresh Tears, 9582X
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label

Further study details as provided by Innovative Medical:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  1. Normal, healthy volunteers 18 years or older
  2. Males or females
  3. Any race or ethnic background

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00469521

Locations
United States, South Carolina
Magill Research Center Institute MUSC
Charleston, South Carolina, United States, 29425
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Helga Sandoval, MS, MD Magill Research Center Institute MUSC
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00469521     History of Changes
Other Study ID Numbers: 5304
Study First Received: May 2, 2007
Last Updated: September 5, 2007
Health Authority: United States:Institution Review Board

ClinicalTrials.gov processed this record on November 20, 2014